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Abstract
IMPORTANCE Hospitals are reimbursed based on Diagnosis Related Groups (DRGs), which are
defined, in part, by patients having 1 or more complications or comorbidities within a given DRG
family. Hospitals have made substantial investment in efforts to document these complications and
comorbidities.
OBJECTIVE To examine temporal trends in DRGs with a major complication or comorbidity,
compare these findings with 2 alternative measures of disease severity, and estimate associated
changes in payment.
DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study used data from the
all-payer National Inpatient Sample for admissions assigned to 1 of the top 20 reimbursed DRG
families at US acute care hospitals from January 1, 2012, to December 31, 2016. Data were analyzed
from July 10, 2018, to May 29, 2019.
EXPOSURES Quarter year of hospitalization.
MAIN OUTCOMES AND MEASURES The primary outcome was the proportion of DRGs with a major
complication or comorbidity. Secondary outcomes were comorbidity scores, risk-adjusted mortality
rates, and estimated payment. Changes in assigned DRGs, comorbidity scores, and risk-adjusted
mortality rates were analyzed by linear regression. Payment changes were estimated for each DRG
by calculating the Centers for Medicare & Medicaid Services weighted payment using 2012 and 2016
case mix and hospitalization counts.
RESULTS Between 2012 and 2016, there were 62 167 976 hospitalizations for the 20 highest-
reimbursed DRG families; the sample was 32.9% male and 66.8% White, with a median age of 57
years (interquartile range, 31-73 years). Within 15 of these DRG families (75%), the proportion of
DRGs with a major complication or comorbidity increased significantly over time. Over the same
period, comorbidity scores were largely stable, with a decrease in 6 DRG families (30%), no change
in 10 (50%), and an increase in 4 (20%). Among 19 DRG families with a calculable mortality rate, the
risk-adjusted mortality rate significantly decreased in 8 (42%), did not change in 9 (47%), and
increased in 2 (11%). The observed DRG shifts were associated with at least $1.2 billion in
increased payment.
CONCLUSIONS AND RELEVANCE In this cohort study, between 2012 and 2016, the proportion of
admissions assigned to a DRG with major complication or comorbidity increased for 15 of the top 20
reimbursed DRG families. This change was not accompanied by commensurate increases in disease
severity but was associated with increased payment.
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Key Points
Question Have the proportion of
inpatient admissions assigned to a
Diagnosis Related Group (DRG) with
major complication or comorbidity and
the associated payments changed
over time?
Findings In this cohort study of US
hospitalizations from 2012 to 2016, the
proportion of DRGs with major
complication or comorbidity increased
for 15 of the top 20 reimbursed DRG
families; however, commensurate
increases in comorbidity burden or risk-
adjusted mortality were not observed.
These DRG shifts were associated with
at least $1.2 billion in increased payment.
Meaning In this study, trends in
assigned DRGs did not reflect trends in
the underlying case mix.
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Introduction
Per capita, the US spends more on health care than any other country worldwide,1 and hospitals
receive the largest share of these dollars.2 In the US, hospitals are paid under the Inpatient
Prospective Payment System, which was introduced in 1983 to reduce health care spending by
predefining hospital reimbursement for given diagnoses and procedures.3,4 The Inpatient
Prospective Payment System categorizes each discharged patient into a Diagnosis Related Group
(DRG) with an assigned payment weight that reflects the average resources used to treat that
condition.5 Payment weights for each DRG are updated annually to account for changes in operating
and capital costs, labor and nonlabor inflation, hospital variability (eg, geography, presence or
absence of quality programs, disproportionate share status), medical education, and potential
upcoding.6,7
There are a total of 761 Medicare Severity–DRGs, which are organized into families (eg, heart
failure) with 2 or 3 levels, most commonly with a base Medicare Severity–DRG (hereafter referred to
as DRG) and 1 or 2 higher-complexity DRGs. Assignment to these latter DRGs occurs if 1 or more
complications or comorbidities (CC) or major complications or comorbidities (MCC) are present. Of
importance, hospital payment for DRGs with CCs or MCCs is often substantially greater. For example,
payment for DRG 291 (heart failure and shock with MCC) is approximately twice that for DRG 293
(heart failure and shock without CC or MCC).
Because DRG assignment is based largely on diagnosis and procedure codes, accuracy of
documentation is important. To that end, most US health care systems have implemented clinical
documentation improvement programs to ensure that a patient’s clinical status is fully represented
in the medical record and subsequently translated into appropriate coding categories.8,9 Clinical
documentation improvement programs have focused much of their attention on more thorough
capture of secondary diagnoses, which can inform the specific DRG assigned within a given DRG
family, often with increased hospital payment.10,11
Assessment of the associations between DRGs, cost, and quality in the US goes back more than
3 decades.12-15 More recently, select DRGs have been used to evaluate key quality programs, such as
the Hospital Value-Based Purchasing and Readmissions Reduction Programs.16,17 Less research as of
late has been focused on associations between DRG shifts, case mix, and hospital payment.
We used all-payer data from the National Inpatient Sample (NIS) to examine the pattern of DRG
assignment for the 20 highest-reimbursed DRG families. We aimed to (1) assess temporal trends in
DRG assignment, particularly in terms of shifts to those with MCC within a given DRG family; (2)
evaluate whether comorbidity scores and risk-adjusted mortality rates (RAMRs), as
DRG-independent markers of disease severity, similarly changed; and (3) estimate changes in
payment associated with these DRG shifts.
Methods
Population and Data Source
This retrospective cohort study used data from the Healthcare Cost and Utilization Project NIS, which
is the largest publicly available, all-payer, inpatient hospital database in the US. Yearly data contain
more than 7 million hospital stays, representing a stratified sample of approximately 20% of
inpatient admissions to nonfederal hospitals (95% sampling frame of all hospital discharges in the
US). The NIS does not contain unique patient identifiers; as such, each hospitalization is treated
independently. This analysis included all inpatient admissions from January 1, 2012, to December 31,
2016, inclusive of the most current data available at the time of the analysis. This study was approved
by the Providence St. Joseph Health institutional review board, with waiver of informed consent
because data were deidentified. The study followed the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting guideline.
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Data on hospitalized patients younger than 18 years of age were excluded except those related
to preterm birth (DRG 791-792: prematurity). Annual national prevalence was estimated using
hospital weight and stratum information provided by the NIS. The annual estimated payment for
each DRG was calculated using publicly available Centers for Medicare & Medicaid Services (CMS)
weighted payments,18 multiplied by annual NIS weighted hospitalization counts. Estimated
payments were summed for all DRGs within a given family, and the 20 DRG families with the highest
payments in 2016 were selected for further analysis. Data were analyzed from July 10, 2018, to May
29, 2019.
Study Outcomes
The primary outcome was the proportion of hospitalizations assigned to a DRG with MCC (or highest-
complexity equivalent) in each DRG family. Secondary outcomes were comorbidity scores (using the
Moore index19), RAMRs, and estimated payment.
The Moore index incorporates 29 comorbidity variables into a single index and represents a
validated means to assess risk-adjusted mortality in large administrative data sets.19 To calculate the
RAMR, multivariable logistic regression models stratified by DRG family were constructed with the
following independent variables: age, sex, race, elective vs nonelective status, and Moore index
score. The RAMR for each DRG was calculated using indirect standardization, defined as the ratio of
the observed rate of the outcome to the expected rate of the outcome in the risk-adjusted model,
multiplied by the unadjusted mortality rate observed in the whole study period.20 One of the DRG
families (DRG 791-792: prematurity) did not have inpatient mortality data and was excluded from the
RAMR calculation.
Statistical Analysis
For each DRG family, the DRG coding percentage, Moore index score, and RAMR were summarized
by quarter-year from the first quarter of 2012 to the fourth quarter of 2016. Quarter-year was chosen
to account for seasonal variation in hospitalization, and the first quarter of 2012 was used as baseline.
To compare temporal changes in these outcomes, we performed 3 linear regressions for each DRG,
with change in DRG coding percentage, Moore index score, or RAMR as dependent variables and
time as the independent variable. For graphical purposes, we fitted a LOESS model, a nonparametric
model using locally weighted polynomial regression, to estimate the association between the
aforementioned dependent variables and quarter-year across our study period. Results from the
linear regression and LOESS models are presented as mean percentage change per quarter with
95% CIs.
To further assess the association between comorbidity burden and temporal changes in DRG
assignment within a given DRG family, a multinomial logistic regression model was performed for the
heart failure DRG family (DRGs 291, 292, and 293). The outcome was DRG assignment for each
hospitalization, with the following independent variables: time (quarter-year), age, sex, race, elective
vs nonelective status, and Moore index score. Results are presented as odds ratios (ORs) with
95% CIs.
To examine payment changes associated with DRG shifts over time, the average weighted
payment for each DRG was multiplied by the coded percentage of that DRG in 2012 or 2016. All DRGs
within a given family were summed and divided by 100 to calculate the average weighted payment
per case in that year. By holding 2012 coding distribution constant and applying CMS weighted
payments from 2016, we calculated the change in reimbursement. We then subtracted this from the
2016 average weighted payments to calculate the reimbursement difference owing to changes in
DRG coding. Additional details are provided in eTable 1 and the eAppendix in the Supplement.
Furthermore, we conducted several sensitivity analyses. We examined whether our risk model
choice (Moore index) was the primary driver of our findings by repeating the analyses with 3 different
comorbidity models. The 29-variable Elixhauser model was originally developed to measure
comorbidities in large administrative data sets.21 The Thompson index reduces the Elixhauser
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variables into a single score and has been validated in the NIS.22 The van Walravan index is a modified
version of the Elixhauser model that also reduces the Elixhauser variables into a single score.23
Similar to our primary analysis, all models in the sensitivity analysis included the top 20 DRG families
and the following covariates: age, sex, race, and elective vs nonelective status.
All hypothesis tests were 2-sided and P < .05 was considered statistically significant. The Tukey
method was used for post hoc multiple comparison testing when needed. SAS, version 9.4 (SAS
Institute Inc) and R, version 1.2.1335 (R Project for Statistical Computing) were used for all analyses.
Results
Sample Characteristics
Between 2012 and 2016, there were 62 167 976 hospitalizations for the 20 highest-reimbursed DRG
families (Table 1). Patients included in this cohort were 32.9% male and 66.8% White, with a median
age of 57 years (interquartile range, 31-73 years). These DRG families accounted for an estimated
12.9 million inpatient hospitalizations in 2016 (36.0% of all hospitalizations) and at least $115.4 billion
in payment. Ten of the 20 DRG families were procedural; the remaining were medical. The top 2 DRG
families, sepsis and lower extremity joint replacement, accounted for approximately one-quarter of
the estimated payment. Volume and payment information (based on CMS weighting) for specific
DRGs are provided in eTable 2 in the Supplement.
Temporal Trends in DRGs With MCCs
For 15 of the 20 DRG families (75%), the proportion of DRGs with MCC increased significantly over
time (Figure 1). For example, for hip and femur procedures (a 3-level DRG family), 17.1% of admissions
in 2012 and 19.4% in 2016 were assigned to a DRG with MCC. Shifts among the 3-level DRG families
were most notable for heart failure, chronic obstructive pulmonary disease, and pneumonia. For
Table 1. Top 20 Reimbursed DRG Families in 2016a
Rank DRG Family Type
NIS unweighted
case volume
NIS weighted
case volume
Estimated
payment,
billions USD
(% of top 20 total)
1 870-872: Sepsis M 323 165 1 615 824 15.59 (13.5)
2 469-470: LE joint replacement P 246 924 1 234 621 14.34 (12.4)
3 774-775: Vaginal delivery M 485 836 2 429 178 8.11 (7.0)
4 3-4: ECMO or tracheostomy P 19 143 95 715 7.86 (6.8)
5 853-855: Infectious diseases P 56 197 280 985 6.77 (5.9)
6 765-766: Cesarean delivery P 244 010 1 220 049 6.21 (5.4)
7 291-293: Heart failure M 183 894 919 470 6.02 (5.2)
8 329-331: Bowel procedure P 71 120 355 600 5.64 (4.9)
9 459-460: Spinal fusion P 46 876 234 380 5.29 (4.6)
10 246-247: PCI with DES P 71 732 358 660 4.73 (4.1)
11 193-195: Pneumonia M 147 953 739 764 4.38 (3.8)
12 682-684: Renal failure M 120 706 603 530 3.73 (3.2)
13 791-792: Prematurity M 50 589 252 945 3.67 (3.2)
14 981-983: Extensive OR procedure P 34 869 174 345 3.58 (3.1)
15 64-66: ICH or stroke M 104 550 522 750 3.45 (3.0)
16 190-192: COPD M 123 294 616 470 3.38 (2.9)
17 219-221: Valve surgery without
cardiac catheterization
P 20 152 100 760 3.35 (2.9)
18 207-208: Respiratory disease M 38 583 192 915 3.33 (2.9)
19 391-392: Esophageal and GI disorders M 140 033 700 164 3.07 (2.7)
20 480-482: Hip and femur procedure
except major joints
P 51 267 256 335 2.92 (2.5)
Total NA NA 2 580 893 12 904 460 115.39
Abbreviations: COPD, chronic obstructive pulmonary
disease; DES, drug-eluting stent; DRG, Diagnosis
Related Group; ECMO, extracorporeal membrane
oxygenation; GI, gastrointestinal; ICH, intracranial
hemorrhage; LE, lower extremity; M, medical; NA, not
applicable; NIS, National Inpatient Sample; OR,
operating room; P, procedural; PCI, percutaneous
coronary intervention.
a Based on Centers for Medicare & Medicaid Services
weighted payments.
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percutaneous coronary intervention (a 2-level DRG family), 17.9% of admissions were assigned to a
DRG with MCC in 2012 compared with 25.2% in 2016. Table 2 shows the mean percentage changes in
DRGs with MCC in each family compared with the first quarter of 2012. Results for all DRGs are
provided in eTable 3 in the Supplement.
Figure 1. Changes in Diagnosis Related Groups (DRGs) Over Time
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Trends in DRG-Independent Measures of Disease Severity
Commensurate changes in disease severity were not observed over time. Moore comorbidity index
scores decreased in 6 DRG families (30%), did not change in 10 (50%), and increased in 4 (20%)
(Table 2). A similar pattern was seen with the RAMR, which significantly decreased in 8 of 19 DRG
families (42%), did not change in 9 (47%), and increased in 2 (11%).
Figure 2 shows quarterly changes in the prevalence, assigned DRGs, comorbidity scores, and
RAMRs for the heart failure DRG family. Hospitalizations for heart failure with higher Moore index
comorbidity scores and those occurring later in the study period were also more likely to be coded as
a DRG with MCC (eFigure 1 in the Supplement).
Consistent results were noted across risk models. Similar comorbidity trends were seen with the
Moore-weighted, Thompson-weighted, and van Walraven–weighted index for those hospitalized
with heart failure (eFigure 2 in the Supplement). Comparable trends for RAMR were seen with the
Moore-weighted index and 29 Elixhauser comorbidities model (eFigure 3 in the Supplement),
mimicking observed trends in the raw mortality rate.
Associated Changes in Payment
From 2012 to 2016, the change in average weighted payment per case using data from CMS varied
from a decrease of $873 for infectious diseases to an increase of $4897 for extracorporeal membrane
oxygenation or tracheostomy with mechanical ventilation (Table 3). For 15 DRG families (75%),
payment associated with shifts in DRG coding increased, ranging from $8 per case for vaginal
delivery to $2057 per case for extracorporeal membrane oxygenation or tracheostomy. Overall,
Table 2. Changes in DRG Categories, Comorbidity Scores, and the Risk-Adjusted Mortality Rate for Admissions Assigned to a DRG With MCC
DRG
Change per quarter vs quarter 1 of 2012, % (95% CI)
P value
Admissions assigned to a DRG
with MCC P value Comorbidity score P value RAMR
870: Sepsis with MV for >96 h –1.91 (–2.48 to –1.34) <.001 0.08 (–0.05 to 0.21) .23 –0.10 (–0.37 to 0.17) .47
469: LE joint replacement with MCC –0.71 (–0.87 to –0.56) <.001 –0.13 (–0.35 to 0.09) .26 –1.19 (–1.9 to –0.49) .004
774: Vaginal delivery with complicating
diagnosis
0.45 (0.18 to 0.71) .004 1.82 (1.34 to 2.31) <.001 –1.04 (–3.47 to 1.39) .41
3: ECMO or tracheostomy with MV for >96 h
with major OR
0.7 (0.34 to 1.06) .001 0.16 (–0.02 to 0.34) .11 0.49 (0.03 to 0.95) .051
853: Infectious diseases with MCC –0.27 (–0.4 to –0.13) .001 –0.17 (–0.31 to –0.04) .02 –0.17 (–0.68 to 0.34) .52
765: Cesarean delivery with CC or MCC 0.72 (0.62 to 0.83) <.001 2.81 (2.47 to 3.16) <.001 1.9 (–3.01 to 6.82) .46
291: Heart failure with MCC 2.37 (1.64 to 3.09) <.001 –0.07 (–0.21 to 0.07) .35 –1.72 (–2.1 to –1.33) <.001
329: Bowel procedure with MCC –0.8 (–1.07 to –0.53) <.001 0.09 (–0.07 to 0.25) .29 –1.08 (–1.4 to –0.76) <.001
459: Spinal fusion with MCC 2.3 (1.45 to 3.16) <.001 –1.03 (–1.86 to –0.2) .03 0.65 (–4.01 to 5.31) .79
246: PCI with DES with MCC 2.58 (2.2 to 2.95) <.001 1.02 (0.63 to 1.41) <.001 1.76 (0.83 to 2.68) .002
193: Pneumonia with MCC 2.29 (2.04 to 2.54) <.001 –0.63 (–0.82 to –0.44) <.001 –1.84 (–2.17 to –1.51) <.001
682: Renal failure with MCC 0.74 (0.32 to 1.15) .003 –0.23 (–0.41 to –0.06) .02 –1.06 (–1.46 to –0.66) <.001
791: Prematurity with major problems 1.29 (1.08 to 1.49) <.001 –3.20 (–4.37 to –2.04) <.001 NAa NAa
981: Extensive OR procedure with MCC 1.18 (0.74 to 1.61) <.001 –0.14 (–0.35 to 0.06) .19 0.25 (–0.59 to 1.09) .57
64: ICH or stroke with MCC 0.94 (0.66 to 1.21) <.001 –0.23 (–0.4 to –0.07) .01 –0.76 (–1.03 to –0.49) <.001
190: COPD with MCC 2.27 (1.82 to 2.72) <.001 0.07 (–0.13 to 0.28) .49 –1.48 (–2.17 to –0.78) <.001
219: Valve surgery without cardiac
catheterization with MCC
0.6 (0.47 to 0.72) <.001 0 (–0.19 to 0.19) .99 –0.69 (–1.37 to –0.01) .06
207: Respiratory disease with MV for >96 h –0.84 (–1.18 to –0.49) <.001 0.01 (–0.19 to 0.21) .93 0.24 (–0.13 to 0.61) .22
391: Esophageal and GI disorders with MCC 1.07 (0.73 to 1.41) <.001 0.67 (0.55 to 0.79) <.001 –1.17 (–2.07 to –0.27) .02
480: Hip and femur procedure except major
joint with MCC
0.76 (0.59 to 0.93) <.001 –0.09 (–0.31 to 0.12) .40 –0.58 (–1.21 to 0.06) .09
Abbreviations: CC, complication or comorbidity; COPD, chronic obstructive pulmonary
disease; DRG, Diagnosis Related Group; ECMO, extracorporeal membrane oxygenation;
GI, gastrointestinal; ICH, intracranial hemorrhage; MCC, major complication or
comorbidity; MV, mechanical ventilation; NA, not applicable; RAMR, risk-adjusted
mortality rate.
a There were no deaths in the prematurity DRG family; hospitalizations during which
death occurred were coded into DRG-789: neonates, died or transferred to another
acute care facility.
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changes in assigned DRGs accounted for at least $1.2 billion more in payment in 2016 than would
have been the case if the 2012 distribution of DRGs remained unchanged.
Discussion
In this cohort study, most of the 20 highest-reimbursed DRG families had a significant shift toward
DRGs with MCC from 2012 to 2016. During the same time, there were inconsistent changes in
comorbidity burden and a largely stable to improving RAMR. These shifts in coding were associated
with at least $1.2 billion more in payment compared with what would have occurred without them.
Of importance, this study revealed an upward shift in admissions assigned to a DRG with MCC
for most of the DRG families evaluated. Among 3-level DRG families, a shift to a DRG with MCC was
most common, with a commensurate decrease in DRGs with no CC or MCC. Similar findings were
observed among many of the 2-level DRG families. The reasons behind these findings are
incompletely understood.
Shifts among the 3-level DRG families were most notable for heart failure, chronic obstructive
pulmonary disease, and pneumonia, all of which are included in the Hospital Readmissions Reduction
Program. This finding raises the possibility that some of the shifts may have been associated with
greater focus on documentation in the context of financial incentives to improve performance for
these particular conditions. There are other potential contributing factors, however. Concurrent with
our observation of a shift to DRGs with MCC from 2012 to 2016, hospital adoption of electronic health
record systems increased24,25 largely in association with meaningful-use incentives under the 2009
Health Information Technology for Economic and Clinical Health Act.26 Hospitals also made
substantial investments in clinical documentation improvement programs27 cognizant of the
reimbursement opportunities associated with a shift to more complex DRGs.8
Figure 2. Temporal Trends in Heart Failure Prevalence, Coded Severity of Disease, Comorbidity Scores, and Risk-Adjusted Mortality Rate
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Another finding of this study was the absence of a consistent increase in comorbidity burden
and largely stable to decreasing RAMRs among admissions assigned to a DRG with MCC over time.
Although the presence of only a single CC or MCC leads to a shift in the DRG assigned, the
comorbidity assessments performed in our study may provide a more comprehensive measure of
patient complexity. As such, our findings call into question whether the observed DRG shifts are a
reflection of a more complex patient population or whether they instead reflect efforts by clinical
documentation improvement programs to encourage documentation of secondary diagnoses (CCs
and MCCs) that result in greater hospital reimbursement.
Similar observations have been noted in other studies examining health care quality,28,29 in
which improved performance has at least in part been attributable to improved documentation. In a
1995 analysis of the New York Cardiac Surgery Reporting System, greater documentation of relevant
comorbidities was considered to account for approximately 40% of observed improvement in the
RAMR.28 More recently, a study using the Medicare Provider Analysis and Review file estimated that
increases in coded severity of disease accounted for approximately 60% of improvement in
readmission rates after implementation of the Hospital Readmissions Reduction Program.29
Analogous patterns were thought to underlie recent reports of decreasing risk-adjusted inpatient
mortality rates for acute myocardial infarction, heart failure, and pneumonia within the Medicare
population.20 Some of these changes were possibly associated with observed shifts in coding, with
an increase in documented comorbidities or assignment of patients to a different DRG family
altogether (eg, from a pneumonia DRG to a septicemia or severe sepsis DRG).30
In addition, DRG shifts were associated with a significant increase in estimated payment over
time. Hospitals had an increase in reimbursement to care for patients who did not appear to be any
Table 3. Payment Changes Associated With Changes in Case Mix Over Time
DRG family
Average weighted payment per case
based on case mix, USD
2012/2016 Payments, million USD per case/per
family (% difference)a
2012 2016 Difference
Owing to CMS payment
difference
Owing to coding
difference
870-872: Sepsis 10 042 9649 –393 –49/–79 (–0.51) –344/–556 (–3.57)
469-470: LE joint
replacement
11 157 11 615 458 490/606 (4.22) –33/–40 (–0.28)
774-775: Vaginal delivery 2906 3339 433 425/1.03 (12.72)b 8/20 (0.25)
3-4: ECMO or tracheostomy
with MV for >96 h
76 947 81 844 4897 2839/272 (3.46) 2057/197 (2.51)
853-855: Infectious
diseases
24 979 24 105 –873 –507/–143 (–2.11) –366/–103 (–1.52)
765-766: Cesarean delivery 5155 5093 –62 –149/–181 (–2.92) 86/106 (1.7)
291-293: Heart failure 5897 6545 648 123/113 (1.88) 525/483 (8.03)
329-331: Bowel procedure 16 089 15 854 –236 348/124 (2.19) –583/–207 (–3.68)
459-460: Spinal fusion 20 689 22 546 1857 1625/381 (7.21) 231/54 (1.03)
246-247: PCI with DES 11 439 13 187 1748 1302/467 (9.87) 446/160 (3.38)
193-195: Pneumonia 5583 6030 447 91/68 (1.54) 355/263 (6.01)
682-684: Renal failure 6188 6179 –9 –182/–110 (–2.95) 174/105 (2.81)
791-792: Prematurity 12 583 14 500 1917 1438/364 (9.92) 478/121 (3.3)
981-983: Extensive OR 19 389 20 755 1366 23/4 (0.11) 1343/234 (6.55)
64-66: ICH or stroke 6466 6593 127 –162/–85 (–2.46) 289/151 (4.38)
190-192: COPD 4978 5482 504 205/127 (3.75) 299/184 (5.45)
219-221: Valve surgery
without cardiac
catheterization
32 333 33 130 798 223/22 (0.67) 575/58 (1.73)
207-208: Respiratory
disease
16 577 17 020 443 1043/201 (6.04) –600/–116 (–3.48)
391-392: Esophageal and GI
disorders
4062 4397 335 282/197 (6.42) 53/37 (1.21)
480-482: Hip and femur
procedure except major joint
10 498 11 444 946 784/201 (6.89) 163/42 (1.43)
Total NA NA NA 3.6 (3.10)b 1.2 (1.03)b
Abbreviations: CMS, Centers for Medicare & Medicaid
Services; COPD, chronic obstructive pulmonary
disease; DES, drug-eluting stent; DRG, Diagnosis
Related Group; ECMO, extracorporeal membrane
oxygenation; GI, gastrointestinal; ICH, intracranial
hemorrhage; LE, lower extremity; NA, not applicable;
OR, operating room; PCI, percutaneous coronary
intervention.
a Based on 2016 weighted case volume and
2016 payment.
b Payments are in billions of USD.
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sicker in terms of overall comorbidities or risk of death but were documented as such. The $1.2 billion
in increased payment is likely an underestimate because our calculations used publicly available CMS
payments applied to an all-payer population. Medicare was the primary payer for only 41.7% of
admissions in this cohort. Although the NIS is an all-payer data set, payment rates for commercial
payers were not available, and thus our estimation of payment was limited to that provided by the
CMS. In prior analyses, payment to hospitals by commercial payers has largely exceeded that
provided by the CMS for nearly all DRGs evaluated.31
In an era during which costs of care continue to increase and value-based care models are
ubiquitous, there is a need to better understand the role that coding plays in increased health care
spending. The CMS could consider moving from the current DRG system, which yields often
significantly greater reimbursement by documenting a CC or MCC, to one in which patient risk is
assessed more broadly. Support for this change would come from an increasing population of
patients with more than 1 comorbidity and acknowledgment that the current DRG system does not
adequately capture varying combinations of comorbidities.32 Most CMS quality and cost measures
use a broader array of International Classification of Diseases, Ninth Revision and International
Statistical Classification of Diseases and Related Health Problems, Tenth Revision diagnosis codes for
both identification and risk adjustment. For example, the model used by CMS to risk adjust its
readmission and mortality measures, along with its cost and utilization measures, contains 83
condition categories and basic demographic information.33
Limitations
This study has limitations. First, because the NIS is an administrative data set, we could not assess
appropriateness of the coded complexity of disease and thus DRG shifts. Significant geographic and
DRG-specific variability in CC and MCC capture rates has been shown,34 with substantial ongoing
opportunity to increase hospital reimbursement.10,35 The shift in DRGs observed in our study may
only reflect a period of catch up to appropriately capture clinical risk. In the absence of audits or of
confirmatory data from a second source, such as electronic health records, it is difficult to know what
represents accurate diagnosis capture. Second, the NIS data set captures inpatient hospitalizations,
not individual patients. Accordingly, we were unable to track other measures that may gauge disease
severity (eg, readmission rates) or any postdischarge outcomes. Furthermore, because the NIS does
not include other admission types (eg, outpatient, observation), additional shifts related to hospital
status could not be assessed. Third, the estimated payments were based on NIS case volumes and
CMS-weighted DRG payments and not on actual Inpatient Protective Payment System payment data.
Fourth, our estimate of increased payment is only for the 20 highest-reimbursed DRG families
(representing 36% of all inpatient admissions) and thus is likely to be an underestimate of total
payment associated with DRG shifts. Fifth, our financial analysis applied Medicare payments to an
all-payer population and likely provides an underestimate of hospital reimbursement from
commercial payers.
Conclusions
This cohort study revealed that, between 2012 and 2016, there were increases in the proportion of
admissions assigned to a DRG with MCC in 15 of the 20 highest-reimbursed DRG families. This change
was not associated with commensurate increases in disease severity as assessed by comorbidity
burden or risk-adjusted mortality. These DRG shifts were associated with at least $1.2 billion in
increased payment.
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